Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Therapeutic Implications in Parkinsonism of m-Tyramine Formation from L-Dopa in Man

Abstract

THE urinary output of m-hydroxyphenylacetic acid is increased during treatment of Parkinsonian patients with L-dopa1 and decreases significantly after administration of neomycin to reduce gut flora2. Thus, it seems that p-dehydroxylation of this type is achieved by intestinal microorganisms3. Whereas earlier animal experiments had suggested that 3,4-dihydroxy-phenylacetic acid is the immediate precursor of m-hydroxy-phenylacetic acid4, we now have evidence of increased m-tyramine formation, indicating that some degree of microbial dehydroxylation of dopamine or of L-dopa itself takes place.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Calne, D. B., Karoum, F., Ruthven, C. R. J., and Sandler, M., Brit. J. Pharmacol. Chemother., 37, 57 (1969).

    CAS  Article  Google Scholar 

  2. 2

    Sandler, M., Karoum, F., Ruthven, C. R. J., and Calne, D. B., Science, 166, 1417 (1969).

    ADS  CAS  Article  Google Scholar 

  3. 3

    Scheline, R. R., Acta Pharmacol. Toxicol., 26, 189 (1968).

    CAS  Article  Google Scholar 

  4. 4

    DeEds, F., Booth, A. N., and Jones, F. T., J. Biol. Chem., 225, 615 (1957).

    CAS  PubMed  Google Scholar 

  5. 5

    Block, R. J., Durrum, E. L., and Zweig, G., Manual of Paper Chromatography and Paper Electrophoresis, second ed. 132 (Academic Press, New York, 1958).

    Google Scholar 

  6. 6

    Kakimoto, Y., and Armstrong, M. D., J. Biol. Chem., 237, 208 (1962).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. 7

    Perry, T. L., and Schroeder, W. A., J. Chromatog., 12, 358 (1963).

    CAS  Article  Google Scholar 

  8. 8

    Coward, R. F., Smith, P., and Wilson, O. S., Clin. Chim. Acta, 9, 381 (1964).

    CAS  Article  Google Scholar 

  9. 9

    Perez-Silva, G., Rodriguez, D., and Perez-Silva, J., Nature, 212, 303 (1966).

    ADS  CAS  Article  Google Scholar 

  10. 10

    Ferrini, R., and Glässer, A., Biochem. Pharmacol., 13, 798 (1964).

    CAS  Article  Google Scholar 

  11. 11

    Mitoma, C., Posner, H. S., Bogdanski, D. F., and Udenfriend, S., J. Pharmacol. Exp. Ther., 120, 188 (1957).

    CAS  PubMed  Google Scholar 

  12. 12

    Blaschko, H., and Chruściel, T. L., J. Physiol., 151, 272 (1960).

    CAS  Article  Google Scholar 

  13. 13

    Blaschko, H., Holton, P., and Sloane Stanley, G. H., J. Physiol., 108, 427 (1949).

    CAS  Article  Google Scholar 

  14. 14

    Calne, D. B., and Sandler, M., Nature, 226, 21 (1970).

    ADS  CAS  Article  Google Scholar 

  15. 15

    Carlsson, A., and Lindqvist, M., Europ. J. Pharmacol., 2, 187 (1967).

    CAS  Article  Google Scholar 

  16. 16

    Andén, N.-E., Butcher, S. G., and Fuxe, K., Acta Pharmacol. Toxicol., 28, 39 (1970).

    Article  Google Scholar 

  17. 17

    Carlsson, A., in Handbook of Experimental Pharmacology (edit. by Erspamer, V.), 19, 529 (Springer, Berlin, 1966).

    Google Scholar 

  18. 18

    Ehringer, H., and Hornykiewicz, O., Klin. Wschr., 38, 1236 (1960).

    CAS  Article  Google Scholar 

  19. 19

    Sandler, M., Proc. Laurentian Meeting on Dopa in Parkinsonism (in the press).

  20. 20

    Hornykiewicz, O., Proc. Laurentian Meeting on Dopa in Parkinsonism (in the press).

  21. 21

    Sourkes, T. L., Biochem. Med., 3, 321 (1970).

    CAS  Article  Google Scholar 

  22. 22

    Smith, R. L., Proc. Symposium on Mechanisms of Toxicity, London (in the press).

  23. 23

    Calne, D. B., Stern, G. M., Laurence, D. R., Sharkey, J., and Armitage, P., Lancet, i, 744 (1969).

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

SANDLER, M., GOODWIN, B., RUTHVEN, C. et al. Therapeutic Implications in Parkinsonism of m-Tyramine Formation from L-Dopa in Man. Nature 229, 414–416 (1971). https://doi.org/10.1038/229414a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing